 
                            
                                    Cancer                                
                                                            ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
 
                            
                                    Featured News                                
                                                            December 1, 2016
                                 
                            
                                    Clinical Trials                                
                                                            December 1, 2016
                                 
                            
                                    Featured News                                
                                                            December 1, 2016
                                 
                            
                                    Featured News                                
                                                            December 1, 2016
                                 
                             
                             
                            
                                    Featured News                                
                                                            November 29, 2016
                                Sign up to receive email notifications
Explore more topics
 Sign up
 Sign up
               
                              Mayo Clinic Connect
An online patient support community
 
                            